前列腺癌,口服型人造抗体 z-bo 2020-09-18 352

　　American scientists have newly developed an artificial antibody, SyAM-Ps, which can be used to treat prostate cancer. It can be taken orally into the human body and can combine with the white blood cells of the immune system to destroy the disease-causing cells.

　　At present, chemists at Yale University in the United States have newly developed a molecule that mimics antibodies, SyAM-Ps, which can be swallowed into the abdomen like ordinary oral drugs, which can mimic the action of antibodies and enhance human immunity.

　　Scientists have developed the first artificial antibody that can attach to disease-causing cells and achieve human immune response. It can mimic the ability of natural antibodies, attach to disease-causing cells and bacteria in the blood, and stimulate white blood cells to kill them. They pointed out that these artificial antibodies can be stored at room temperature, providing novel and convenient disease treatment measures, and are expected to treat cancer and other stubborn diseases.

　　Yale University chemistry expert, Dr. David Spiegel (David Spiegel) is responsible for the development of this artificial antibody. He pointed out that this molecular substance can be taken orally in pills like painkillers and antibiotics. He led a research team that has used these antibodies to attack prostate cancer cells.

　　They hope that similar molecules can be used to treat other cancers, bacterial infections, and even AIDS. Dr. Pigle said: "Different from natural antibodies, our newly developed molecules are made of man-made organic compounds and account for only 20% of the volume of natural antibodies. One part."

　　Because this molecule has a unique thermally stable structure, it is unlikely to cause an adverse immune response. They can be taken orally into the human body, just like swallowing ordinary small molecular structure drugs. Currently, this latest research report is published in the recently published "American Chemical Society" magazine.